SofWave Medical Ltd. is a medical device company specializing in non-invasive aesthetic technologies, with headquarters in Israel and California. The firm's primary focus is developing and commercializing advanced ultrasound-based solutions for skin rejuvenation, targeting facial lines, wrinkles, and improving the appearance of cellulite. Its flagship technology uses Synchronous Ultrasound Parallel Beam methods, enabling treatments that stimulate collagen, elastin, and hyaluronic acid production for firmer, revitalized skin—all without needles or invasive procedures. The device is FDA-cleared and designed for use by plastic surgeons, dermatologists, and other aesthetic medicine professionals, providing a quick, clinically proven, and safe option for patients of various skin types.

Founded in 2015, SofWave Medical has rapidly expanded its global presence and earned a reputation for innovative treatment models, strong industry partnerships, and recognized clinical effectiveness. The company's technology is distributed internationally and is supported by technical and clinical service offerings, ensuring a comprehensive solution for healthcare providers in the growing aesthetics sector. SofWave Medical plays a significant role in the medical aesthetics industry, contributing to the advancement of non-invasive skin treatments.